Brenton Bauer
@BrentonBauerMD
Los Angeles South Bay Cardiologist with COR Healthcare Associates. Passionate about #Cardiology #Prevention #Cardiooncology and #CVImaging. Tweets are my own.
ID:906251950634680325
http://linkedin.com/in/brenton-bauer-md-657a3a52 08-09-2017 20:24:37
1,1K Tweets
1,2K Followers
994 Following
Hey #SoCal CardioNerds, check out this Women's Heart Symposium, virtual & in-person on Fri Oct 28th👇🏽
🔗torrancememorial.org/healthy-living…
Nadia Jafar Curran Brenton Bauer Karol Watson Michelle Kittleson MD PhD Nisha Parikh California ACC Jamal Rana, MD Dr. Purvi Parwani Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Eric H Yang, MD
#CardioOncology Web Rounds by California ACC Check it out!👇
Jamal Rana, MD Brenton Bauer Eric H Yang, MD Jacqueline Vuong
Excited to see our #bruinhearts UCLA Cardiology Fellowship chief #celsodiaz & Department of Medicine at UCLA Health ⭐️ Jacqueline Vuong present this California ACC #cardioonc kickoff of “❤️ on 🔥” presenting ICI related cases!
Led by Brenton Bauer w/ UCLA Jonsson Comprehensive Cancer Center #deborahwong co-paneling, don’t miss it!
UCLA Internal Medicine Chief Residents
Humbled and excited to be a part of such a great speaker panel at the inaugural Women’s Heart Symposium Torrance Memorial
The prettiest summary of HF clinical trials 🫀😍
#GDMTworks #CardioTwitter
ACCP Cardiology PRN
jacc.org/doi/epdf/10.10…
Our work on #ACCEarlyCareer challenges in JACC Journals today- especially focusing on juggling parenting responsibilities with clinical/research/societal duties
Wonderful collaborating w/ Matthew Sherwood, MD, MHS Mike Cullen Poonam Velagapudi
sciencedirect.com/science/articl…
More to come on this!
The first major paper from our PREVENT study has been published! We're very excited to share our findings with NEJM Evidence and the rest of the scientific community. #CVresearch #PREVENT tinyurl.com/5n8vfk3y
Exciting news in the #amyloidosis world with the success of APOLLO-B showing the success of a #silencer treatment ( #patisiran ) for the first time in a Phase 3 study designed for #ATTR -CM. 🍾 Several thoughts to follow… businesswire.com/news/home/2022…
✅Our article:
The cumulative doses of anthracyclines (>225 mg/m2), pazopanib initiation at age ≥60 yrs, and the baseline BNP (≥50 pg/mL) initiation were predictive factors for post-pazopanib treatment HF.
#Pazopanib #HeartFailure #Sarcoma
#CardioOnc
👉pubmed.ncbi.nlm.nih.gov/35314578/